Related Experiment Video
Updated: Jul 3, 2026

Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness
Published on: May 3, 2018
Relationship between arterial stiffness and myocardial damage in patients with newly diagnosed essential hypertension
Omer Gedikli1, Serkan Ozturk, Hulya Yilmaz
1Faculty of Medicine, Department of Cardiology, Karadeniz Technical University, Trabzon, Turkey. omergedikli@yahoo.com
Insights
Arterial stiffness is elevated in new hypertension cases. Increased arterial stiffness and body mass index are linked to higher heart-type fatty acid-binding protein (H-FABP) levels, a marker of heart damage.
Area of Science:
- Cardiology
- Hypertension Research
- Biomarker Discovery
Background:
- Arterial stiffness is a known complication of hypertension (HT), impacting cardiac function.
- Serum heart-type fatty acid-binding protein (H-FABP) is a sensitive indicator of myocardial damage.
- The association between arterial stiffness and H-FABP in newly diagnosed HT patients was previously unexamined.
Purpose of the Study:
- To investigate the relationship between serum H-FABP levels and arterial stiffness in individuals with newly diagnosed hypertension.
- To determine if arterial stiffness is a determinant of H-FABP levels in this population.
Main Methods:
- A study involving 46 never-treated hypertensive patients and 40 normotensive controls.
- Measurement of serum H-FABP levels using standard assays.
- Assessment of arterial stiffness and wave reflections via applanation tonometry, including carotid-femoral pulse wave velocity (PWV) and heart rate-corrected augmentation index (AIx@75).
Main Results:
- Hypertensive patients exhibited significantly higher carotid-femoral PWV and AIx@75 compared to controls.
- Serum H-FABP levels were significantly elevated in the hypertensive group.
- Multiple linear regression identified body mass index and carotid-femoral PWV as significant determinants of H-FABP levels.
Conclusions:
- Arterial stiffness is significantly associated with elevated serum H-FABP levels in patients with newly diagnosed hypertension.
- These findings suggest a link between vascular changes and myocardial strain in early hypertension.
Background:
Arterial stiffness increases in hypertensive individuals. Arterial stiffness is associated with impairment of systolic and diastolic myocardial function in hypertension (HT). However, the relationship between arterial stiffness and serum heart-type fatty acid-binding protein (H-FABP) levels, a sensitive marker of myocardial damage, has not been previously examined in patients with HT. We investigate the relationship between serum H-FABP levels and arterial stiffness in patients with newly diagnosed HT.
Methods:
We studied 46 (48.5 +/- 10.6, years) never-treated patients with HT and age-matched control group of 40 (47 +/- 8.6, years) normotensive individuals. H-FABP levels were determined in all subjects. We evaluated arterial stiffness and wave reflections of study population, using applanation tonometry (Sphygmocor). Carotid-femoral pulse wave velocity (PWV) was measured as indices of elastic-type, aortic stiffness. The heart rate-corrected augmentation index (AIx@75) was estimated as a marker of wave reflections.
Results:
Carotid-femoral PWV (10.5 +/- 2.2 vs. 8.7 +/- 1.6, m/s, P = 0.0001) and AIx@75 (22.7 +/- 9.5 vs. 15 +/- 11, %, P = 0.001) were significantly higher in patients with HT than control group. H-FABP levels were increased in hypertensive patients compared with control group (21.1 +/- 14.8 vs. 12.9 +/- 8.5, ng/ml, P = 0.002). In multiple linear regression analysis, we found that the body mass index (beta = 0.42, P = 0.0001) and carotid-femoral PWV (beta = 0.23, P = 0.03) were significant determinants of H-FABP levels.
Conclusion:
Arterial stiffness is associated with serum H-FABP levels, a sensitive marker of myocardial damage, in patients with newly diagnosed HT.
Related Concept Videos
Coronary Artery Disease I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Hypertension II: Pathophysiology
Coronary Artery Disease II: Pathophysiology
Hypertension and Regulation of Blood Pressure
